JP2018512408A5 - - Google Patents

Download PDF

Info

Publication number
JP2018512408A5
JP2018512408A5 JP2017549107A JP2017549107A JP2018512408A5 JP 2018512408 A5 JP2018512408 A5 JP 2018512408A5 JP 2017549107 A JP2017549107 A JP 2017549107A JP 2017549107 A JP2017549107 A JP 2017549107A JP 2018512408 A5 JP2018512408 A5 JP 2018512408A5
Authority
JP
Japan
Prior art keywords
triazolo
pyridin
benzonitrile
cyano
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017549107A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018512408A (ja
JP6726681B2 (ja
Filing date
Publication date
Priority claimed from GBGB1504565.1A external-priority patent/GB201504565D0/en
Application filed filed Critical
Publication of JP2018512408A publication Critical patent/JP2018512408A/ja
Publication of JP2018512408A5 publication Critical patent/JP2018512408A5/ja
Application granted granted Critical
Publication of JP6726681B2 publication Critical patent/JP6726681B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017549107A 2015-03-18 2016-03-17 Phd阻害剤としての縮合二環式ヘテロアリール誘導体 Active JP6726681B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1504565.1A GB201504565D0 (en) 2015-03-18 2015-03-18 Novel compounds
GB1504565.1 2015-03-18
PCT/JP2016/059782 WO2016148306A1 (en) 2015-03-18 2016-03-17 Fused bicyclic heteroaryl derivatives having activity as phd inhibitors

Publications (3)

Publication Number Publication Date
JP2018512408A JP2018512408A (ja) 2018-05-17
JP2018512408A5 true JP2018512408A5 (enExample) 2019-04-25
JP6726681B2 JP6726681B2 (ja) 2020-07-22

Family

ID=53051992

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017549107A Active JP6726681B2 (ja) 2015-03-18 2016-03-17 Phd阻害剤としての縮合二環式ヘテロアリール誘導体

Country Status (31)

Country Link
US (1) US10287286B2 (enExample)
EP (1) EP3271357B1 (enExample)
JP (1) JP6726681B2 (enExample)
KR (1) KR102609431B1 (enExample)
CN (1) CN107531698B (enExample)
AU (1) AU2016234209B2 (enExample)
BR (1) BR112017019653B1 (enExample)
CA (1) CA2979024C (enExample)
CL (1) CL2017002354A1 (enExample)
CO (1) CO2017009353A2 (enExample)
CR (1) CR20170468A (enExample)
DK (1) DK3271357T3 (enExample)
DO (1) DOP2017000209A (enExample)
EA (1) EA035739B1 (enExample)
EC (1) ECSP17069696A (enExample)
ES (1) ES2774052T3 (enExample)
GB (1) GB201504565D0 (enExample)
GE (2) GEP20207095B (enExample)
HU (1) HUE047918T2 (enExample)
IL (1) IL254277B (enExample)
MX (1) MX2017011902A (enExample)
MY (1) MY194873A (enExample)
NZ (1) NZ735631A (enExample)
PE (1) PE20180656A1 (enExample)
PH (1) PH12017501699B1 (enExample)
PT (1) PT3271357T (enExample)
SG (1) SG11201707280VA (enExample)
TN (1) TN2017000384A1 (enExample)
UA (1) UA123668C2 (enExample)
WO (1) WO2016148306A1 (enExample)
ZA (1) ZA201706612B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX383747B (es) 2016-02-24 2025-03-14 Pfizer Derivados de pirazolo[1,5-a]pirazin-4-ilo como inhibidores de quinasas janus (jak)
WO2019034973A1 (en) 2017-08-14 2019-02-21 Pfizer Inc. PYRAZOLO [1,5-A] PYRAZIN-4-YL AND RELATED DERIVATIVES
DK3808747T3 (da) * 2018-09-13 2025-02-03 Kissei Pharmaceutical Imidazopyridinon-forbindelse
AU2020368368B2 (en) * 2019-10-14 2026-03-19 The Regents Of The University Of California Broad spectrum anti-cancer compounds
CN110950806A (zh) * 2019-11-14 2020-04-03 安庆博曼生物技术有限公司 四乙基氯化铵催化嘧啶环羟基氯代制备方法
JP7504822B2 (ja) * 2020-03-12 2024-06-24 キッセイ薬品工業株式会社 イミダゾピリジノン化合物を含む医薬組成物
US11718622B2 (en) 2020-03-16 2023-08-08 Exelixis Inc. Heterocyclic adenosine receptor antagonists
AR121626A1 (es) 2020-03-20 2022-06-22 Akebia Therapeutics Inc Compuestos inhibidores de phd, composiciones y métodos de uso
CN115413277B (zh) * 2020-04-20 2023-08-01 深圳市塔吉瑞生物医药有限公司 吡嗪取代的烟酰胺的固体形式及其制备和用途
JP7654071B2 (ja) * 2020-10-20 2025-03-31 アムジエン・インコーポレーテツド 複素環スピロ化合物及び使用方法
US12492178B2 (en) 2021-09-01 2025-12-09 Empathbio, Inc. Stable polymorph of R-MDMA HCl
WO2023072240A1 (en) 2021-10-28 2023-05-04 Insilico Medicine Ip Limited Prolyl hydroxylase domain-containing protein (phd) inhibitors and uses thereof
JP2025500892A (ja) * 2021-12-17 2025-01-15 アケビア セラピューティクス インコーポレイテッド 選択的phd1阻害剤化合物、組成物、及び使用方法
US11912680B2 (en) 2021-12-28 2024-02-27 Empathbio, Inc. Nitric oxide releasing prodrugs of MDA and MDMA

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4209621A (en) 1979-04-27 1980-06-24 American Cyanamid Company (Substituted-phenyl)-1,2,4-triazolo[4,3-a]-pyrimidines and (substituted-phenyl)-1,2,4-triazolo[1,5-a]pyrimidines
DK135184A (da) * 1983-03-03 1984-10-10 Riker Laboratories Inc Triazol(4,3-c)- og triazol(1,5-c)pyrimidiner
US4572910A (en) * 1983-03-03 1986-02-25 Riker Laboratories, Inc. Triazolo[1,5-c]pyrimidines substituted by nitrogen-containing heterocyclic rings
NZ523807A (en) 2000-06-30 2004-09-24 Wyeth Corp Substituted-triazolopyrimidines as anticancer agents
JP2010065026A (ja) 2008-08-13 2010-03-25 Ishihara Sangyo Kaisha Ltd ピリジル−トリアゾロピリミジン誘導体又はその塩、並びにそれらを含有する有害生物防除剤
JP2010065024A (ja) 2008-08-14 2010-03-25 Ishihara Sangyo Kaisha Ltd トリアゾロピリミジン誘導体又はその塩を含有する有害生物防除剤
US8283465B2 (en) * 2009-07-17 2012-10-09 Japan Tobacco Inc. Triazolopyridine compound, and action thereof as prolyl hydroxylase inhibitor or erythropoietin production-inducing agent
JP2011168582A (ja) 2010-01-21 2011-09-01 Ishihara Sangyo Kaisha Ltd トリアゾロピリジン誘導体又はその塩、それらの製造方法及びそれらを含有する有害生物防除剤
JPWO2014030716A1 (ja) 2012-08-23 2016-08-08 田辺三菱製薬株式会社 ピラゾロピリミジン化合物

Similar Documents

Publication Publication Date Title
JP2021502356A5 (enExample)
JP2017530999A5 (enExample)
JP2023525762A5 (enExample)
JP2010513283A (ja) 新規なオキサジアゾール化合物
RU2016141645A (ru) ИНГИБИТОРЫ TrkA КИНАЗЫ, ОСНОВАННЫЕ НА НИХ КОМПОЗИЦИИ И СПОСОБЫ
RU2012104493A (ru) Замещенные соединения пиразоло [1,5-a] пиримидина как ингибиторы киназы trk
RU2017116598A (ru) Соединения и композиции для модуляции киназной активности мутантов egfr
RU2013155456A (ru) Соединения пирролидинилмочевины и пирролидинилтиомочевины как ингибиторы киназы trka
RU2017121044A (ru) Производные амидотиадиазола в качестве ингибиторов надфн-оксидазы
RU2017135520A (ru) Бициклические производные хиназолинона
JP2016517878A5 (enExample)
JP2008516982A5 (enExample)
JP2010510319A5 (enExample)
JP2019515931A5 (enExample)
JP2019512482A5 (enExample)
RU2012143794A (ru) Производные n-(имидазопиримидин-7-ил)-гетероаламидов и их применение в качестве ингибиторов pde10a
GB2609879A (en) Antagonists of the adenosine A2a receptor
RU2019132212A (ru) Селективные ингибиторы hdac6
RU2015112580A (ru) Ингибиторные соединения
CA2610888A1 (en) Inhibitors of akt activity
HRP20140770T1 (hr) SUPSTITUIRANI SPOJEVI N-(1H-INDAZOL-4-IL)IMIDAZO[1,2-a]PIRIDIN-3-KARBOKSAMIDA KAO INHIBITORI CFMS
JP2017512794A5 (enExample)
RU2006134021A (ru) Производные гетероарил-конденсированного пиразола
CN103857392A (zh) 用于治疗增生性疾病的2-甲酰胺环氨基尿素衍生物与Hsp90抑制剂的组合
JP2017508766A5 (enExample)